FDA Denies Accelerated Approval for ALS Drug

 The FDA has rejected Clene Nanomedicine’s application for accelerated approval for the experimental drug ALS drug, CNM-Au8, citing insufficient evidence.
Medscape Medical News

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart